Hamideh Parhiz

4.8k total citations · 6 hit papers
37 papers, 2.7k citations indexed

About

Hamideh Parhiz is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Hamideh Parhiz has authored 37 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Genetics and 5 papers in Oncology. Recurrent topics in Hamideh Parhiz's work include RNA Interference and Gene Delivery (21 papers), Virus-based gene therapy research (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Hamideh Parhiz is often cited by papers focused on RNA Interference and Gene Delivery (21 papers), Virus-based gene therapy research (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Hamideh Parhiz collaborates with scholars based in United States, Iran and Sweden. Hamideh Parhiz's co-authors include Fatemeh Soltani, Mehrdad Iranshahi, Ramin Rezaee, Ali Roohbakhsh, Drew Weissman, Vladimir R. Muzykantov, Mohammad Ramezani, Vladimir V. Shuvaev, Makan Khoshnejad and Elena N. Atochina‐Vasserman and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Hamideh Parhiz

34 papers receiving 2.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of their Molecular Mechanisms and Experimental Models

2014 719 citations Hamideh Parhiz, Ali Roohbakhsh et al. profile →
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

2021 183 citations Hamna Shahnawaz, Amir Yadegari et al. profile →
In vivo hematopoietic stem cell modification by mRNA delivery

2023 176 citations Laura Breda, Tyler E. Papp et al. profile →
PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake

2018 154 citations Hamideh Parhiz, Vladimir V. Shuvaev et al. Journal of Controlled Release profile →
mRNA-based therapeutics: looking beyond COVID-19 vaccines

2024 112 citations Hamideh Parhiz, Elena N. Atochina‐Vasserman et al. The Lancet profile →
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism

2023 108 citations Margaret M. Billingsley, Alvin J. Mukalel et al. profile →

Peers

Countries citing papers authored by Hamideh Parhiz

Since Specialization

Citations

This map shows the geographic impact of Hamideh Parhiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamideh Parhiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamideh Parhiz more than expected).

Fields of papers citing papers by Hamideh Parhiz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamideh Parhiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamideh Parhiz. The network helps show where Hamideh Parhiz may publish in the future.

Co-authorship network of co-authors of Hamideh Parhiz

This figure shows the co-authorship network connecting the top 25 collaborators of Hamideh Parhiz. A scholar is included among the top collaborators of Hamideh Parhiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamideh Parhiz. Hamideh Parhiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering 2026 ·bioRxiv (Cold Spring Harbor Laboratory) ·(unknown), Tyler E. Papp, (unknown), (unknown), Lanfranco Leo, (unknown), Hamideh Parhiz	0
2	Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction–associated steatohepatitis 2026 ·Science Translational Medicine ·Chittampalli N. Yashaswini, Bruno Cogliati, (unknown), (unknown), (unknown), Tyler E. Papp, (unknown), (unknown), (unknown), (unknown), Haig Aghajanian, Hamideh Parhiz, Shuang Wang, Joel G. Rurik, (unknown), (unknown)	0
3	In Situ Tumor Vaccination Using Lipid Nanoparticles to Deliver Interferon-β mRNA Cargo 2025 ·Vaccines ·Kenji Kimura, (unknown), (unknown), (unknown), Caitlin M. Tilsed, Karen P. Fong, Tyler E. Papp, Steven Μ. Albelda, Hamideh Parhiz, Jarrod D. Predina	1
4	An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA 2024 ·Blood ·(unknown), Laura Breda, Tyler E. Papp, (unknown), Enrico Radaelli, Charles‐Antoine Assenmacher, (unknown), Barbara L. Mui, Ying K. Tam, (unknown), Chiara Riganti, Veronica Fiorito, Sara Petrillo, Emanuela Tolosano, Hamideh Parhiz, Stefano Rivella	0
5	IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation 2024 ·Proceedings of the National Academy of Sciences ·Caitlin M. Tilsed, (unknown), Tyler E. Papp, (unknown), Kenji Kimura, Estela Noguera-Ortega, John Scholler, (unknown), Haig Aghajanian, Adrian Bot, Barbara L. Mui, Ying K. Tam, Drew Weissman, Carl H. June, Steven Μ. Albelda, Hamideh Parhiz	24
6	mRNA-based therapeutics: looking beyond COVID-19 vaccines breakdown → 2024 ·The Lancet ·Hamideh Parhiz, Elena N. Atochina‐Vasserman, Drew Weissman	112
7	Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system 2024 ·Molecular Therapy — Nucleic Acids ·Hamideh Parhiz, Vladimir V. Shuvaev, Qin Li, Tyler E. Papp, (unknown), (unknown), Amir Yadegari, Hamna Shahnawaz, Sean C. Semple, Barbara L. Mui, Drew Weissman, Vladimir R. Muzykantov, Patrick M. Glassman	11
8	Oxidized mRNA Lipid Nanoparticles for In Situ Chimeric Antigen Receptor Monocyte Engineering 2024 ·Advanced Functional Materials ·Alvin J. Mukalel, Alex G. Hamilton, Margaret M. Billingsley, (unknown), Ajay S. Thatte, Xuexiang Han, Hannah C. Safford, Marshall S. Padilla, Tyler E. Papp, Hamideh Parhiz, Drew Weissman, Michael J. Mitchell	26
9	Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis 2023 ·Haematologica ·(unknown), Hamideh Parhiz, Stefano Rivella	8
10	CRISPR/Cas9-Mediated Genetic Engineering of Hybridomas for Creation of Antibodies that Allow for Site-Specific Conjugation 2019 ·Methods in molecular biology ·Makan Khoshnejad, (unknown), Hamideh Parhiz, Vladimir R. Muzykantov	3
11	PECAM-1 directed re-targeting of exogenous mRNA providing two orders of magnitude enhancement of vascular delivery and expression in lungs independent of apolipoprotein E-mediated uptake breakdown → 2018 ·Journal of Controlled Release ·Hamideh Parhiz, Vladimir V. Shuvaev, Norbert Pardi, Makan Khoshnejad, Raisa Y. Kiseleva, (unknown), (unknown), Steven Tuyishime, Barbara L. Mui, Ying K. Tam, Thomas D. Madden, Michael J. Hope, Drew Weissman, Vladimir R. Muzykantov	154
12	Ferritin-based drug delivery systems: Hybrid nanocarriers for vascular immunotargeting 2018 ·Journal of Controlled Release ·Makan Khoshnejad, Hamideh Parhiz, Vladimir V. Shuvaev, Ivan J. Dmochowski, Vladimir R. Muzykantov	114
13	Effective and safe in vivo gene delivery based on polyglutamic acid complexes with heterocyclic amine modified-polyethylenimine 2018 ·Colloids and Surfaces B Biointerfaces ·Zahra Salmasi, Ahad Mokhtarzadeh, Maryam Hashemi, Mahboubeh Ebrahimian, Sara Amel Farzad, Hamideh Parhiz, Mohammad Ramezani	15
14	Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery 2015 ·Current Pharmaceutical Design ·Fatemeh Soltani, Hamideh Parhiz, Ahad Mokhtarzadeh, Mohammad Ramezani	80
15	Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases 2015 ·Life Sciences ·Ali Roohbakhsh, Hamideh Parhiz, Fatemeh Soltani, Ramin Rezaee, Mehrdad Iranshahi	308
16	PEGylation of Polypropylenimine Dendrimer with Alkylcarboxylate Chain Linkage to Improve DNA Delivery and Cytotoxicity 2015 ·Applied Biochemistry and Biotechnology ·Maryam Hashemi, (unknown), Hamideh Parhiz, Ahad Mokhtarzadeh, (unknown), Mohammad Ramezani	18
17	Protective effects of flavonoids against microbes and toxins: The cases of hesperidin and hesperetin 2015 ·Life Sciences ·Mehrdad Iranshahi, Ramin Rezaee, Hamideh Parhiz, Ali Roohbakhsh, Fatemeh Soltani	176
18	In vitro protective effects of Scutellaria litwinowii root extract against H ₂ O ₂ -induced DNA damage and cytotoxicity 2014 ·Journal of Complementary and Integrative Medicine ·(unknown), Hamideh Parhiz, (unknown), Seyed Ahmad Emami, Javad Asili, Javad Behravan, Fatemeh Mosaffa	5
19	Neuropharmacological properties and pharmacokinetics of the citrus flavonoids hesperidin and hesperetin — A mini-review 2014 ·Life Sciences ·Ali Roohbakhsh, Hamideh Parhiz, Fatemeh Soltani, Ramin Rezaee, Mehrdad Iranshahi	163
20	Gene Transfer Enhancement by Alkylcarboxylation of Poly(propylenimine) 2013 ·SHILAP Revista de lepidopterología ·Maryam Hashemi, (unknown), Sara Amel Farzad, Hamideh Parhiz, Mohammad Ramezani	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact